HaiHe Biopharma
PrivateLast Round
Private Placement
Sep 26, 2025
Est. Valuation
$525.3M
Total Funding Raised
$363.8M
Company Overview
HaiHe Biopharma is a biotechnology company that specializes in the discovery, development, and commercialization of innovative anti-tumor drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HaiHe Biopharma Comparables
Compare HaiHe Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apollomics | 88% | |
| Avistone Pharmaceuticals | 86% | |
| HUTCHMED (China) Limited | 82% | |
HaiHe Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Sep 26, 2025 | ||||
| IPO | May 28, 2024 | ||||
| Series C | Jun 1, 2023 | ||||
| IPO | Sep 22, 2021 | ||||
| Strategic | Aug 10, 2021 | ||||
Series B | Jul 27, 2020 |
HaiHe Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guotai Junan Securities (Hong Kong) Limited | IPO |
| BioTrack Capital | Series A, Series B |
| Boyuan Capital | Series A |
| CCIC Capital | Series B |
| Jiangsu Ruihua Investment Holding Group Co., Ltd. | Series B |
| Hillhouse Investment | Series A |
| 招银国际金融有限公司 | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 28, 2024
$403M raised in IPO round.
- Sep 22, 2021
IPO round led by Guotai Junan Securities (Hong Kong) Limited.
HaiHe Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HaiHe Biopharma's valuation, stock price, and market status.